首页> 外国专利> compounds, pharmaceutical composition, method for treating fibrotic condition, therapeutically effective amount of compound, pharmaceutically acceptable salt thereof or pharmaceutical composition and uses thereof and of compounds and / or pharmaceutical composition

compounds, pharmaceutical composition, method for treating fibrotic condition, therapeutically effective amount of compound, pharmaceutically acceptable salt thereof or pharmaceutical composition and uses thereof and of compounds and / or pharmaceutical composition

机译：化合物，药物组合物，治疗纤维化病的方法，治疗有效量的化合物，其药学上可接受的盐或药物组合物及其用途以及化合物和/或药物组合物

页面导航

摘要
著录项
相似文献

摘要

"Compounds, pharmaceutical composition, method for treating fibrotic condition, therapeutically effective amount of compound, pharmaceutically acceptable salt thereof or pharmaceutical composition and uses thereof and compounds and / or pharmaceutical composition" summary are disclosed pyridinone compounds, methods for preparing them and methods for treating fibrotic disorders. 530/530 1/1

机译：“化合物，药物组合物，治疗纤维化病的方法，治疗有效量的化合物，其药学上可接受的盐或药物组合物及其用途以及化合物和/或药物组合物”概述公开了吡啶酮类化合物，其制备方法和治疗方法纤维化疾病。 530/530 1/1

著录项

公开/公告号BR112015006341A2

专利类型
公开/公告日2017-07-04

原文格式PDF
申请/专利权人 INTERMUNE INC.;
展开▼

申请/专利号BR20151106341
发明设计人 BRAD OWEN BUCKMAN;JOHN BEAMOND NICHOLAS;JOHNNIE Y. RAMPHAL;KUMARASWAMY EMAYAN;SCOTT D. SEIWERT;
展开▼

申请日2013-10-01
分类号C07D205/08;A61K31/381;A61K31/4035;A61K31/427;A61K31/4412;A61K31/4418;A61K31/4439;A61K31/444;A61K31/4545;A61K31/501;A61K31/513;A61K31/522;A61K31/5377;A61K31/538;A61K31/539;A61K31/541;A61P1/16;A61P11;A61P17/02;A61P19/04;C07C13/06;C07D207/267;C07D209/34;C07D209/38;C07D209/48;C07D211/76;C07D211/84;C07D211/86;C07D221/04;C07D223/10;C07D237/14;C07D401/04;C07D401/12;C07D401/14;C07D403/04;C07D405/04;C07D405/14;C07D409/12;C07D409/14;C07D413/04;C07D413/14;C07D417/04;C07D417/10;C07D417/12;C07D417/14;C07D471/04;C07D473/06;C07D473/28;C07D473/32;C07D487/04;C07D491/048;C07D495/04;C07D498/04;C07D513/04;
国家 BR
入库时间 2022-08-21 13:40:15

相似文献

专利
外文文献
中文文献